SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Jonas A) srt2:(1995-1999)"

Sökning: WFRF:(Jonas A) > (1995-1999)

  • Resultat 1-25 av 33
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Nilsson, Henrik, et al. (författare)
  • Laser-induced fluorescence studies of the biodistribution of carotenoporphyrins in mice
  • 1997
  • Ingår i: British Journal of Cancer. - : Springer Science and Business Media LLC. - 0007-0920 .- 1532-1827. ; 76:3, s. 355-364
  • Tidskriftsartikel (refereegranskat)abstract
    • The biodistribution of two recently developed tumour markers, trimethylated (CP(Me)3) and trimethoxylated (CP(OMe)3) carotenoporphyrin, was investigated by means of laser-induced fluorescence (LIF) after i.v. injection into 38 tumour-bearing (MS-2 fibrosarcoma) female Balb/c mice. At 3, 24, 48 or 96 h after administration, the carotenoporphyrin fluorescence was measured in tumoral and peritumoral tissue, as well as in the abdominal, thoracic and cranial cavities. The fluorescence was induced by a nitrogen laser-pumped dye laser, emitting light at 425 nm, and analysed by a polychromator equipped with an image-intensified CCD camera. The fluorescence was evaluated at 490, 655 and 720 nm: the second and third wavelengths represent the carotenoporphyrin (CP)-related peaks, whereas the first one is close to the peak of the tissue autofluorescence. The tumour and the liver were the two tissue types showing the strongest carotenoporphyrin-related fluorescence, whereas the cerebral cortex and muscle consistently exhibited weak substance-related fluorescence. In most tissue types, the fluorescence intensities decreased over time. A few exceptions were observed, notably the liver, in which the intensity remained remarkably constant over the time period investigated.
  •  
3.
  •  
4.
  • Bergquist, Jonas, et al. (författare)
  • Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis.
  • 1997
  • Ingår i: Electrophoresis. - : Wiley. - 0173-0835 .- 1522-2683. ; 18:10, s. 1760-6
  • Tidskriftsartikel (refereegranskat)abstract
    • Single cell analysis with capillary electrophoresis, a technique capable of detecting zeptomole quantities (10(-21) mole) of neurochemical species, has been used to demonstrate that lymphocytes are capable of active synthesis of dopamine and norepinephrine. Exposure of lymphocytes to catecholamines at concentrations as low as 10 nM leads to decreased proliferation and differentiation, e.g. interferon-gamma (IFN-gamma), interleukin-4 (IL-4) and immunoglobulin (Ig). In addition, both inhibition of dopamine uptake with nomifensine and inhibition of packing of catecholamines into vesicles with tetrabenazine, results in significantly lower levels of dopamine and norepinephrine (p < 0.01 and p < 0.05, respectively). The catecholamine-dependent inhibition of T- and B-lymphocyte activity is mediated via an induction of a Bcl-2/Bax and Fas/FasL involved apoptosis. These findings indicate a novel mechanism for regulation of lymphocyte activity in the central nervous system, whereby elevated regional levels of catecholamines might lead to the immunoprivilege of the brain.
  •  
5.
  •  
6.
  • Lindberg, Gunnar, et al. (författare)
  • Serum sialic acid and sialoglycoproteins in asymptomatic carotid artery atherosclerosis. ARIC Investigators. Atherosclerosis Risk in Communities
  • 1999
  • Ingår i: Atherosclerosis. - 1879-1484. ; 146:1, s. 65-69
  • Tidskriftsartikel (refereegranskat)abstract
    • Serum total sialic acid (S-TSA) is a recently identified risk marker for atherosclerosis and cardiovascular mortality. The purpose of this study was to evaluate the influence of three sialic acid rich glycoproteins (orosomucoid, haptoglobin, and alpha1-antitrypsin) on the relationship between S-TSA and carotid atherosclerosis. The mean S-TSA was 0.045 g/l higher among cases than controls (P<0.001) in 310 45-64 year-old male and female pairs of carotid atherosclerosis cases and disease-free controls from the Atherosclerosis Risk in Communities (ARIC) Study. Also mean serum levels of the glycoproteins were significantly higher in cases compared to controls. In a conditional multiple logistic regression model with the glycoproteins as independent variables, orosomucoid was correlated most strongly with case control status. However, when incorporated into the mathematical model, S-TSA not only contributed additional information as to the risk of atherosclerosis; none of the three glycoproteins contributed further once S-TSA had been accounted for. Thus, some other source of serum sialic acid or variations in the degree of sialylation of glycoproteins may be essential for understanding the relation between S-TSA and atherosclerosis.
  •  
7.
  •  
8.
  • BENBADIS, L, et al. (författare)
  • WORKING GROUP-VII - FOOD-PRODUCTS
  • 1995
  • Ingår i: MICROBIAL ECOLOGY IN HEALTH AND DISEASE. - 0891-060X. ; 8, s. S43-S44
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
9.
  •  
10.
  • Bergh, Jonas C., et al. (författare)
  • The first clinical pilot study of roquinimex (Linomide) in cancer patients with special focus on immunological effects
  • 1997
  • Ingår i: Cancer Investigation. - 0735-7907 .- 1532-4192. ; 15:3, s. 204-11
  • Tidskriftsartikel (refereegranskat)abstract
    • Roquinimex (Linomide) has been demonstrated to suppress tumor growth in animal models. The effect is at least in part related to enhanced numbers and activity of natural killer (NK) cells. In this clinical pilot study, roquinimex was given at increasing doses (0.05 mg/kg to 0.6 mg/kg) to 13 patients (performance status 0-3) with various malignant disorders. Immunology parameters were followed and side effects were observed during the study. The plasma pharmacokinetics of roquinimex was studied at the 0.2 mg/kg dose level. The clinical side effects were dominated by musculoskeletal discomfort, nausea, and pain. No significant hematological or biochemical toxicity was observed. Pharmacokinetic analysis at the 0.2 mg/kg dose level revealed a Cmax of 4.0 mumol/L at tmax of 1.2 hr and an elimination half-life of 42 hr. Increased numbers of phenotypic NK cells, activated T (DR+CD4+) cells, and monocytes were observed after administration of roquinimex compared with pretreatment values. Roquinimex seems to be an active immunomodulator with manageable toxicity. Further exploration of therapeutic efficacy is warranted.
  •  
11.
  •  
12.
  • Blomqvist, M, et al. (författare)
  • Identification of defensins in human lymphocyte nuclei
  • 1999
  • Ingår i: European Journal of Biochemistry. - : Wiley. - 0014-2956 .- 1432-1033. ; 263:2, s. 312-8
  • Tidskriftsartikel (refereegranskat)abstract
    • The cell nucleus plays an essential role in all aspects of cell function and regulation. Most of the nuclear proteins/peptides are synthesized in the cytoplasm and transported into the nucleus through the nuclear pore complexes. The nuclear proteins/peptides conjugate with each other and interact in transcriptional activation/inactivation. Several of the high molecular mass transcription factors (> 30 kDa) have been identified and characterized. However, the information on the low molecular mass proteins/peptides of the nucleus is limited. We have investigated these low molecular mass proteins/peptides from the nucleus of human peripheral blood lymphocytes using reversed-phase high-performance liquid chromatography (RP-HPLC). The HPLC fractions were further analysed by matrix assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry, electrospray ionization time of flight (ESI-TOF) mass spectrometry and electrospray ionization fourier transform ion cyclotron resonance (ESI-FTICR) mass spectrometry for mass determination. Using this combination of mass spectrometry techniques and microsequence analysis, we have shown that human lymphocyte nuclei contain defensins, a mixture of human neutrophil granule peptide 1, 2 and 3.
  •  
13.
  •  
14.
  •  
15.
  •  
16.
  • Erjefält, Jonas, et al. (författare)
  • Cytolysis and piecemeal degranulation as distinct modes of activation of airway mucosal eosinophils
  • 1998
  • Ingår i: Journal of Allergy and Clinical Immunology. - 1097-6825. ; 102:2, s. 286-294
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Cytotoxic eosinophil granule proteins are considered important in the pathogenesis of inflammatory airway diseases, including asthma, rhinitis, and polyposis. However, little is known about the mechanisms involved in the deposition of these tissue-damaging granular products in vivo. OBJECTIVE: We sought to determine the occurrence of degranulating eosinophils, those with morphologic evidence of cytolysis with associated clusters of free eosinophil granules (Cfegs), and to identify the frequency of apoptotic eosinophils in inflamed upper airway tissue. METHODS: Eosinophil-rich nasal polyps were processed for transmission electron microscopy and for light microscopic evaluation of whole-mount preparations subjected to deep tissue staining for eosinophil peroxidase. RESULTS: The mean proportion of eosinophil subtypes were intact and resting (6.8%), intact but degranulating (83%), cytolytic or Cfegs (9.9%), and apoptotic (0.0%). All degranulating eosinophils exhibited piecemeal degranulation. The occurrence of Cfegs was confirmed in nonsectioned whole-mount preparations. Depending on the appearance of their core and matrix, the specific granules were divided into four subtypes, and a degranulation index (altered per total granules) was calculated for each eosinophil. Cytolytic eosinophils had a much lower degranulation index than intact eosinophils present in the same tissue (P < .001). CONCLUSIONS: These data indicate that eosinophil cytolysis is present in human airway mucosa, that its occurrence is not an artifact of the means of tissue handling, and that cytolysis of eosinophils may occur without prior extensive degranulation. We suggest that eosinophil cytolysis is a major activation mechanism, which occurs along with, but is distinct from, other types of degranulation.
  •  
17.
  •  
18.
  •  
19.
  •  
20.
  • Josefsson, E, et al. (författare)
  • Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis.
  • 1996
  • Ingår i: Immunology. - 0019-2805 .- 1365-2567. ; 88:1, s. 140-6
  • Tidskriftsartikel (refereegranskat)abstract
    • The immune and the nervous systems are anatomically closely related and interact with each other by molecules common to both systems, such as cytokines and neurotransmitters. The purpose of this study was to investigate the participation of catecholamines in the neuroimmunological network. The ability of immune cells to produce catecholamines was examined by a highly sensitive capillary electrophoresis assay, which permits detection of easily oxidized catecholamines in the zeptomole (10(-21)) range. In addition, the effects of catecholamines on in vitro proliferation, differentiation and apoptosis of lymphocytes were assessed. Mouse spleen cells and macrophages contained on average 7 x 10(-17) and 2 x 10(-17) mole dopamine per cell, respectively. In the former cell population also norepinephrine was found. Several mouse B- and T-cell hybridomas were also shown to contain endogenously produced dopamine in levels ranging from 7 x 10(-20) to 2 x 10(-18) mole dopamine per cell. In addition, one of the T-cell hybridomas proved to synthesize norepinephrine. The dopamine production of lymphocytes was blocked by the tyrosine hydroxylase inhibitor alpha-methyl-p-tyrosine, whereas incubation with the precursor L-DOPA increased the dopamine content. Incubation with L-DOPA, dopamine and norepinephrine dose-dependently suppressed mitogen induced proliferation and differentiation of mouse lymphocytes. Even short-time pretreatment of lymphocytes with L-DOPA and dopamine strongly suppressed lymphocyte proliferation and cytokine production. Incubation of lymphoid cells with L-DOPA, dopamine and norepinephrine dose-dependently induced apoptosis which, at least partly, explains the suppressive effects of catecholamines on lymphocyte function. Our results demonstrate that catecholamines: (i) are actively produced by lymphocytes and (ii) have the capacity to act as auto- and/or paracrine regulators of lymphocyte activity through induction of apoptosis.
  •  
21.
  • Juditsky, A., et al. (författare)
  • Nonlinear black-box models in system identification: Mathematical foundations
  • 1995
  • Ingår i: Automatica. - Linköping : Elsevier BV. - 0005-1098 .- 1873-2836. ; 31:12, s. 1725-1750
  • Tidskriftsartikel (refereegranskat)abstract
    • We discuss several aspects of the mathematical foundations of the nonlinear black-box identification problem. We shall see that the quality of the identification procedure is always a result of a certain trade-off between the expressive power of the model we try to identify (the larger the number of parameters used to describe the model, the more flexible is the approximation), and the stochastic error (which is proportional to the number of parameters). A consequence of this trade-off is the simple fact that a good approximation technique can be the basis of a good identification algorithm. From this point of view, we consider different approximation methods, and pay special attention to spatially adaptive approximants. We introduce wavelet and 'neuron' approximations, and show that they are spatially adaptive. Then we apply the acquired approximation experience to estimation problems. Finally, we consider some implications of these theoretical developments for the practically implemented versions of the 'spatially adaptive' algorithms. Copyright © 1995 Elsevier Science Ltd All rights reserved.
  •  
22.
  • Karlsson, Karl-Anders, 1935, et al. (författare)
  • Unexpected carbohydrate cross-binding by Escherichia coli heat-labile enterotoxin. Recognition of human and rabbit target cell glycoconjugates in comparison with cholera toxin.
  • 1996
  • Ingår i: Bioorganic & medicinal chemistry. - 0968-0896. ; 4:11, s. 1919-28
  • Tidskriftsartikel (refereegranskat)abstract
    • The bacterial protein enterotoxins, cholera toxin (CT) of Vibrio cholerae and heat-labile toxin (LT) of Escherichia coli, induce diarrhea by enhancing the secretory activity of the small intestine of man and rabbit (animal model). This physiological effect is mediated by toxin binding to a glycolipid receptor, the ganglioside GM1, Gal beta 3GalNAc beta 4(NeuAc alpha 3)GAl beta 4Glc beta 1Cer. However, LT, but not CT, was recently shown by us to bind also to paragloboside, Gal beta 4GlcNAc beta 3Gal beta 4Glc beta 1Cer, identified in the target cells. By molecular modeling of this tetrasaccharide in the known binding site of LT, the saccharide-peptide interaction was shown to be limited to the terminal disaccharide (N-acetyllactosamine). This sequence is expressed in many glycoconjugates, and we have therefore assayed glycolipids and glycoproteins prepared from the target tissues. In addition to paragloboside, receptor activity for LT was detected in glycoproteins of human origin and in polyglycosylceramides of rabbit. However, CT bound only to GM1. Two variants of LT with slightly different sequences, human (hLT) and porcine (pLT), were identical in their binding to target glycoproteins and polyglycosylceramides, but different regarding paragloboside, which was positive for pLT but negative for hLT. This difference is discussed on basis of modeling, taking in view the difference at position 13, with Arg in pLT and His in hLT. Although N-acetyllactosamine is differently recognized in form of paragloboside by the two toxin variants, we speculate that this sequence in human glycoproteins and rabbit polyglycosylceramides is the basis for the common binding. Much work remains, however, to clear up up this unexpected sophistication in target recognition.
  •  
23.
  •  
24.
  •  
25.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-25 av 33
Typ av publikation
tidskriftsartikel (25)
konferensbidrag (4)
rapport (1)
doktorsavhandling (1)
bokkapitel (1)
licentiatavhandling (1)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (28)
övrigt vetenskapligt/konstnärligt (5)
Författare/redaktör
Åkerström, Göran (6)
Bergquist, Jonas (4)
Blomberg, Jonas (3)
Johansson, Jonas (3)
Hellman, Per (3)
Hjalmarsson, Håkan, ... (2)
visa fler...
Svanberg, Sune (2)
Ljung, Lennart, 1946 ... (2)
Larsson, C (2)
Ridefelt, Peter (2)
KLARESKOG, L (1)
Nilsson, Henrik (1)
Waidringer, Jonas (1)
Johansson, B (1)
Erjefält, Jonas (1)
Holmberg, L (1)
Bergström, Gunnar (1)
Greiff, Lennart (1)
Johansson, Thomas (1)
Hofner, K (1)
Andersson, M (1)
Ekbom, A (1)
Cohen, P (1)
Adbo, Karina (1)
Nicholls, Ian A. (1)
Andersson, Håkan S. (1)
Ankarloo, Jonas (1)
Karlsson, Jesper G. (1)
Norell, M C (1)
Olofsson, Linus (1)
Svenson, Johan (1)
Örtegren, U (1)
Haendler, L (1)
Katzir, A (1)
Svanberg, Katarina (1)
Oberg, K (1)
Nilsson-Ehle, Peter (1)
Henriksson, G (1)
Nilsson, S. (1)
Oberg, Kjell (1)
Lindberg, Gunnar (1)
Uhlen, M (1)
Teneberg, Susann, 19 ... (1)
Eriksson, A (1)
Rask, L. (1)
Råstam, Lennart (1)
Kishk, A. (1)
Sturfelt, G (1)
Fredriksson, Jonas, ... (1)
Hannappel, J. (1)
visa färre...
Lärosäte
Uppsala universitet (15)
Lunds universitet (7)
Chalmers tekniska högskola (4)
Linköpings universitet (3)
Kungliga Tekniska Högskolan (2)
Karolinska Institutet (2)
visa fler...
Göteborgs universitet (1)
Malmö universitet (1)
Mittuniversitetet (1)
Linnéuniversitetet (1)
Högskolan i Borås (1)
visa färre...
Språk
Engelska (33)
Forskningsämne (UKÄ/SCB)
Teknik (7)
Naturvetenskap (6)
Medicin och hälsovetenskap (4)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy